Impact of Common Cold Viruses on Immune Responses to SARS-CoV-2

Research Background

A recent study suggests that prior exposure to common cold viruses may influence the diverse immune responses observed in individuals infected with the SARS-CoV-2 virus. Previous investigations by the same research team revealed that individuals who had not been exposed to SARS-CoV-2 still possessed memory helper T cells that reacted to the virus. This unexpected finding prompted further exploration into whether these T cells were a result of previous encounters with common cold coronaviruses. The findings of this study were published in the latest issue of the journal Science.

Study Methodology

The study utilized samples collected from March 2015 to March 2018, focusing on participants who had not been exposed to SARS-CoV-2. Researchers selected immune cells from these individuals that demonstrated reactivity to SARS-CoV-2. By examining these cross-reactive immune cells, the scientists identified specific parts of the SARS-CoV-2 virus recognized by these immune cells. They also compared these fragments with those from four strains of coronaviruses responsible for common colds.

Key Findings

Employing a technique to detect activated T cells, the research team demonstrated that the reactive T cells recognizing SARS-CoV-2 fragments also cross-reacted with similar fragments from common cold viruses. This finding provides direct evidence that certain populations carry memory immune cells developed from previous infections with common cold viruses, which also respond to SARS-CoV-2. Dr. Daniela Weiskopf, co-lead on the study, stated, “We have now proven that, in some people, pre-existing T cell memory against common cold coronaviruses can cross-recognize SARS-CoV-2, down to the exact molecular structures.”

Implications for Immune Response

The presence of these memory immune cells may enhance the immune system’s ability to recognize and combat SARS-CoV-2. Dr. Alessandro Sette, co-lead on the study, explained, “Immune reactivity may translate to different degrees of protection. Having a strong T cell response, or a better T cell response may give you the opportunity to mount a much quicker and stronger response.” This could potentially clarify why some individuals experience milder COVID-19 symptoms compared to others. However, the researchers caution that drawing definitive conclusions about the relationship between pre-existing immune cells against common cold viruses and the severity of COVID-19 is premature and speculative.

Additional Insights

The study also indicates that the spike protein, a primary focus of SARS-CoV-2 research, is not the sole component of the virus that elicits responses from immune cells. Other viral components also activate T cells, underscoring the importance of T cells, alongside antibody-producing B cells, in the fight against SARS-CoV-2. Nevertheless, it remains uncertain whether prior infections with common cold viruses offer protection against SARS-CoV-2.

Conclusion

This research provides valuable insights into the immune responses to SARS-CoV-2 and highlights the potential role of past coronavirus infections. However, further studies are necessary to understand the implications fully.

References

Mateus J, Grifoni A, Tarke A, et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans [published online ahead of print, 2020 Aug 4]. Science. 2020.

Image by mattthewafflecat from Pixabay.